Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Buy
3,547
+12
+0.3% +$1.39K 0.1% 124
2026
Q1
$422K Buy
3,535
+360
+11% +$47.2K 0.11% 108
2025
Q4
$432K Buy
3,175
+6
+0.2% +$863 0.11% 114
2025
Q3
$467K Buy
3,169
+6
+0.2% +$832 0.13% 104
2025
Q2
$409K Buy
3,163
+7
+0.2% +$848 0.12% 111
2025
Q1
$377K Sell
3,156
-491
-13% -$60.8K 0.12% 115
2024
Q4
$423K Buy
3,647
+8
+0.2% +$1.01K 0.13% 113
2024
Q3
$491K Buy
3,639
+524
+17% +$70.1K 0.14% 108
2024
Q2
$423K Buy
3,115
+8
+0.3% +$1.09K 0.13% 114
2024
Q1
$402K Hold
3,107
0.13% 119
2023
Q4
$355K Hold
3,107
0.13% 117
2023
Q3
$301K Hold
3,107
0.12% 124
2023
Q2
$350K Sell
3,107
-1,039
-25% -$110K 0.14% 120
2023
Q1
$434K Hold
4,146
0.19% 96
2022
Q4
$458K Buy
+4,146
New +$435K 0.24% 91

Other funds holding XYL

Carr Financial Group's XYL Position: Q2 2026 in Review

Carr Financial Group increased its Xylem (XYL) stake by 0.34% in Q2 2026, buying an estimated $1.39K and bringing the position to 3,547 shares worth $419K. The position accounts for 0.1% of the portfolio, ranked #124.

Carr Financial Group first reported a position in XYL in Q4 2022 and has held it in 15 quarters since. The position peaked at $491K in Q3 2024. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Carr Financial Group held 3,547 shares of Xylem worth $419K as of Q2 2026.
  • Carr Financial Group bought 12 Xylem shares in Q2 2026, an estimated $1.39K.
  • Xylem made up 0.1% of Carr Financial Group's portfolio in Q2 2026, its #124 holding.
  • Carr Financial Group first reported a position in Xylem in Q4 2022 and has held it in 15 quarters since.
  • Carr Financial Group's Xylem position peaked at $491K in Q3 2024.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.